Advertisement

Topics

Search Results for "New Treatment For Hepatitis B"

07:55 EDT 25th July 2016 | BioPortfolio

Matching Channels

Hepatitis B

Hepatitis A

Hepatitis C

Most hepatitis C virus (HCV) infected individuals seeking treatment are chronically infected. Treatment goal is to achieve a sustained virological response (SVR), which is the absence of serum HCV R...

Hepatitis E virus HEV

Hepatitis B virus HBV

Matching News

Deciding on the Best Treatment in Patients With Hepatitis B

Recent recommendations and their impact on the management of patients with hepatitis B, including immune-tolerant hepatitis B, immune-active hepatitis B, and inactive chronic hepatitis, are reviewed. ...

Introducing Epclusa

The treatment options for hepatitis C infections just gained a member to the club. There are six genotypes (numbered 1-6) of the hepatitis C virus. Previously, hepatitis C medications generally worked...

The Hepatitis C Trust considers legal action over cap on NHS patients allowed to seek treatment

NHS England is limiting treatment with new drugs for hepatitis C to 10,000 of the most in-need patients, prompting The Hepatitis C Trust to consider seeking a judicial review of the decision.

Longevity After Hepatitis C Treatment

Before direct-acting antiviral medications came on the scene for treating hepatitis C, this disease was often a death sentence for patients who progressed to liver failure or liver cancer. However, ov...

An Unforeseen Complication of the New Hepatitis C Drugs

Hepatitis B might flare during treatment for hepatitis C.

Mycophenolate mofetil effective as first-line treatment for autoimmune hepatitis

In a real-world retrospective study, researchers found mycophenolate mofetil treatment to be safe and effective for the treatment of autoimmune hepatitis in treatment-naive patients, according to publ...

Hepatitis C Treatment Delivery Mandates

This Viewpoint describes how a shortage of health care workers providing treatment for hepatitis C hinders access to treatment, despite progress in drug efficacy and reductions in drug costs.

FDA approves a Gilead pill that is first to treat all forms of hepatitis C

The drug maker's new treatment can be used for all six strains of hepatitis C, and at about $75,000 for a 12-week course of treatment, it costs less than two…

Matching PubMed Articles

The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service.

Hepatitis C treatment uptake in Australia is low. To increase access to hepatitis C virus treatment for people who inject drugs, we developed a community-based, nurse-led service that linked a viral h...

The New Era of Interferon-Free Treatment of Chronic Hepatitis C.

Within the development and approval of several new direct-acting antivirals (DAA) against hepatitis C virus (HCV), a new era of hepatitis C therapy has begun. Even more treatment options are likely to...

PREVALENCE OF OCCULT HEPATITIS B INFECTION IN IRANIAN CANCER PATIENTS BEFORE CHEMOTHERAPY TREATMENT.

Occult hepatitis B infection is characterized by negative hepatitis B surface antigen (HBsAg) and also detectable hepatitis B virus (HBV) -DNA, with or without hepatitis B core antibody (anti-HBc). HB...

Efficacy and safety of entecavir versus tenofovir treatment in chronic hepatitis B patients: A randomized controlled trial.

Entecavir (ETV) and Tenofovir Disoproxil Fumarate (TDF) have been considered among the most potent antiviral agents for the treatment of chronic hepatitis B infection. We aimed to compare treatment ef...

 Effects of a multidisciplinary approach on the effectiveness of antiviral treatment for chronic hepatitis C.

 Background. Despite the introduction of direct antiviral agents, pegylated interferon remains the mainstay of treatment for chronic hepatitis C. However, pegylated interferon is associated with a hi...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement